Shriram Revankar Sells 3,000 Shares of Dolby Laboratories (NYSE:DLB) Stock

Dolby Laboratories (NYSE:DLB) SVP Shriram Revankar sold 3,000 shares of Dolby Laboratories stock in a transaction on Friday, May 15th. The shares were sold at an average price of $54.90, for a total transaction of $164,700.00. Following the completion of the sale, the senior vice president directly owned 80,603 shares in the company, valued at $4,425,104.70. This represents a 3.59% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Dolby Laboratories Stock Performance

Dolby Laboratories stock opened at $53.98 on Thursday. The company’s fifty day moving average price is $60.42 and its 200 day moving average price is $63.50. Dolby Laboratories has a 1 year low of $52.45 and a 1 year high of $77.00. The stock has a market capitalization of $5.11 billion, a P/E ratio of 21.34 and a beta of 0.86.

Dolby Laboratories (NYSE:DLB) last released its quarterly earnings results on Thursday, April 30th. The electronics maker reported $1.37 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.31 by $0.06. Dolby Laboratories had a net margin of 17.85% and a return on equity of 11.47%. The firm had revenue of $395.63 million for the quarter, compared to analysts’ expectations of $385.80 million. During the same quarter last year, the company earned $1.34 EPS. The firm’s revenue for the quarter was up 7.0% compared to the same quarter last year. Dolby Laboratories has set its FY 2026 guidance at 4.300-4.450 EPS and its Q3 2026 guidance at 0.560-0.710 EPS. Sell-side analysts predict that Dolby Laboratories will post 3.22 EPS for the current year.

Dolby Laboratories Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, May 20th. Investors of record on Tuesday, May 12th were issued a $0.36 dividend. This represents a $1.44 annualized dividend and a yield of 2.7%. The ex-dividend date was Tuesday, May 12th. Dolby Laboratories’s payout ratio is presently 56.92%.

Wall Street Analyst Weigh In

DLB has been the topic of several research analyst reports. Wall Street Zen cut Dolby Laboratories from a “buy” rating to a “hold” rating in a report on Saturday, January 31st. Barrington Research reaffirmed an “outperform” rating and set a $90.00 target price on shares of Dolby Laboratories in a research note on Monday, April 27th. Rosenblatt Securities reaffirmed a “buy” rating and set a $85.00 target price on shares of Dolby Laboratories in a research note on Friday, January 30th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Dolby Laboratories in a research note on Friday, March 27th. Three equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, Dolby Laboratories has an average rating of “Moderate Buy” and an average price target of $90.75.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of the company. Vanguard Group Inc. boosted its position in shares of Dolby Laboratories by 2.7% during the 3rd quarter. Vanguard Group Inc. now owns 7,756,924 shares of the electronics maker’s stock valued at $561,369,000 after acquiring an additional 203,411 shares during the last quarter. State Street Corp boosted its position in shares of Dolby Laboratories by 8.7% during the 2nd quarter. State Street Corp now owns 2,261,059 shares of the electronics maker’s stock valued at $167,906,000 after acquiring an additional 180,072 shares during the last quarter. First Trust Advisors LP boosted its position in shares of Dolby Laboratories by 19.9% during the 1st quarter. First Trust Advisors LP now owns 2,254,933 shares of the electronics maker’s stock valued at $135,431,000 after acquiring an additional 374,405 shares during the last quarter. Geode Capital Management LLC boosted its position in shares of Dolby Laboratories by 15.6% during the 4th quarter. Geode Capital Management LLC now owns 1,885,246 shares of the electronics maker’s stock valued at $122,749,000 after acquiring an additional 254,250 shares during the last quarter. Finally, AQR Capital Management LLC boosted its position in shares of Dolby Laboratories by 51.8% during the 2nd quarter. AQR Capital Management LLC now owns 1,736,260 shares of the electronics maker’s stock valued at $128,935,000 after acquiring an additional 592,282 shares during the last quarter. Institutional investors and hedge funds own 58.56% of the company’s stock.

About Dolby Laboratories

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.